Postdoctoral Research Assistant in Skin Immunology and Single-cell Genomics

We are offering an exciting and unique opportunity for an experienced postdoctoral researcher to work on an interdisciplinary, multi-centre project aiming to identify antigens targeted by T cells mediating Graft-versus-Host Disease (GvHD) and Graft-versus-Leukaemia (GvL) following stem cell transplantation (SCT) as a treatment for blood cancers. In this role you will carry out collaborative projects with colleagues in partner institutions, and research groups and write up experimental results, methodology and interpretation which will contribute to reports when required. You will develop, establish, and pursue appropriate analytical protocols and techniques to support research, including standardized protocols for patient sample flows. You will also develop research questions within a specific context, conduct individual research, analysing detailed and complex qualitative and/or quantitative data from a variety of sources, and generate original ideas by building on

Grade 8: Grade 8: Salary in the range of £49,199-£58,265 per annum. This is inclusive of a pensionable Oxford University Weighting of £1,730 per year. This is a full time (100%), fixed term position until 30/06/2029. A lower grade offer (Grade 7: £39,424 - £47,779 per annum) may be made to a less experienced candidate if a suitable candidate cannot be found to fill the Grade 8 position. The University of Oxford is a stimulating work environment, which enjoys an international reputation as a world-class centre of excellence. Our research plays a key role in tackling many global challenges, from reducing our carbon emissions to developing vaccines during a pandemic. The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is part of the Medical Sciences Division and is the largest European academic department in its field, running a globally competitive programme of research and teaching. The Kennedy Institute is a biomedical research centre uniquely bringing together discovery science and early-stage clinical research, to develop transformative new therapies for chronic inflammatory and musculoskeletal conditions. The Dendrou group is an interdisciplinary team whose research aims to compare inflammatory diseases and immunological responses across tissues, over time and upon perturbation for translational benefit, leveraging tissue profiling through multiomic technologies in conjunction with cutting-edge computational and machine learning approaches. What We Offer As an employer, we genuinely care about our employees' wellbeing and this is reflected in the range of benefits that we offer including:

• An excellent contributory pension scheme
• 38 days annual leave
• A comprehensive range of childcare services
• Family leave schemes
• Cycle loan scheme
• Discounted bus travel and Season Ticket travel loans